N-hydroxy-4-((4-((2-methylquinolin-4-yl)methoxy)phenyl)sulfonyl)-1-pivaloylpiperazine-2-carboxamide

ID: ALA4102106

Chembl Id: CHEMBL4102106

PubChem CID: 137660566

Max Phase: Preclinical

Molecular Formula: C27H36N4O6S

Molecular Weight: 544.67

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1cc(COc2ccc(S(=O)(=O)N3CCN(C(=O)C(C)(C)C)C(C(=O)NO)C3)cc2)c2c(n1)CCCC2

Standard InChI:  InChI=1S/C27H36N4O6S/c1-18-15-19(22-7-5-6-8-23(22)28-18)17-37-20-9-11-21(12-10-20)38(35,36)30-13-14-31(26(33)27(2,3)4)24(16-30)25(32)29-34/h9-12,15,24,34H,5-8,13-14,16-17H2,1-4H3,(H,29,32)

Standard InChI Key:  XPKONFJMLMUKJB-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4102106

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 544.67

Molecular Weight (Monoisotopic): 544.2356

AlogP: 2.60

#Rotatable Bonds: 6

Polar Surface Area: 129.14

Molecular Species: NEUTRAL

HBA: 7

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 8.71

CX Basic pKa: 6.55

CX LogP: 2.59

CX LogD: 2.51

Aromatic Rings: 2

Heavy Atoms: 38

QED Weighted: 0.42

Np Likeness Score: -1.39

References

1. Ouvry G, Berton Y, Bhurruth-Alcor Y, Bonnary L, Bouix-Peter C, Bouquet K, Bourotte M, Chambon S, Comino C, Deprez B, Duvert D, Duvert G, Hacini-Rachinel F, Harris CS, Luzy AP, Mathieu A, Millois C, Pascau J, Pinto A, Polge G, Reitz A, Reversé K, Rosignoli C, Taquet N, Hennequin LF..  (2017)  Identification of novel TACE inhibitors compatible with topical application.,  27  (8): [PMID:28274635] [10.1016/j.bmcl.2017.02.035]

Source

Source(1):

• Scientific Literature